{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-038711","form_type":"8-K","ticker":"RGNX","cik":"0001590877","company_name":"REGENXBIO Inc.","filed_at":"2025-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.100413+00:00","generated_at":"2026-05-24T21:18:28.737492+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"REGENXBIO reports Q4 net loss $51.2M; BLA for RGX-121 submitted, Nippon Shinyaku partnership closed","bullets":["Net loss $51.2M ($1.01/sh) in Q4 2024 vs $62.9M; full year $227.1M ($4.59/sh) vs $263.5M. Revenue $83.3M vs $90.2M.","BLA for RGX-121 (MPS II) submitted; FDA approval expected 2H 2025. Nippon Shinyaku deal closed: $110M upfront, up to $700M milestones.","RGX-202 Duchenne pivotal trial nearly 50% enrolled; completion expected 2025, BLA mid-2026. Phase I/II data show favorable safety and functional improvement.","Cash and securities $244.9M at Dec 31, 2024 (vs $314.1M). With $110M Nippon upfront, cash runway into 2H 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-038711","json":"https://secwatch.observer/filing/0000950170-25-038711.json","markdown":"https://secwatch.observer/filing/0000950170-25-038711.md","text":"https://secwatch.observer/filing/0000950170-25-038711.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590877/000095017025038711/0000950170-25-038711-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590877/000095017025038711/rgnx-20250313.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T21:18:28.737492+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}